Dermatology Doctors in Janesville, WI Accepting Medicare

4 Dermatology doctors found. Showing 1 - 4

David D. Nelsen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3524 E Milwaukee St, Janesville, WI 53546 Phone: 608-756-7217    Fax: 608-756-4700

Dr. Lauren Nibler Craddock, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000    Fax: 608-371-8922

Bruce R Pearson, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 580 N Washington St, Dean Medical Center, Janesville, WI 53548 Phone: 608-755-3500    Fax: 608-755-3500

Kristi E Knuijt, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000    Fax: 608-371-8922

News Archive

Scripps CHAVD wins $129 million NIH grant to advance new HIV vaccine approach

The Scripps Consortium for HIV/AIDS Vaccine Development, an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to advance next-generation vaccines designed to coax the immune system into producing antibodies capable of disarming numerous strains of HIV.

Knocking down a single gene can help stop stress from causing infertility, miscarriage

Scientists from the University of California Berkeley have discovered that by knocking down a single gene, they can stop stress from causing female infertility and miscarriage - in rats.

Researchers find difficult to kill Salmonella biofilms with three types of disinfectant

Once Salmonella bacteria get into a food processing facility and have an opportunity to form a biofilm on surfaces, it is likely to be extraordinarily difficult, if not impossible, to kill it, according to research published ahead of print in the journal Applied and Environmental Microbiology.

Data results of NCI-MATCH trial in tumors with DNA mismatch repair deficiencies

Final results are published from an evaluation of 42 patients treated with the immune checkpoint inhibitor nivolumab in the large multi-arm precision medicine trial, NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131).

Read more Medical News

› Verified 7 days ago